A detailed history of Capstone Investment Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 10,940 shares of MRNA stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,940
Previous 49,800 78.03%
Holding current value
$1.27 Million
Previous $4.95 Million 76.47%
% of portfolio
0.0%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$85.37 - $115.44 $259,012 - $350,244
3,034 Added 38.38%
10,940 $1.17 Million
Q4 2023

Feb 12, 2024

SELL
$69.51 - $104.43 $3.26 Million - $4.9 Million
-46,956 Reduced 85.59%
7,906 $786,000
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $1.35 Million - $1.78 Million
14,050 Added 34.43%
54,862 $5.67 Million
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $2.49 Million - $3.37 Million
20,978 Added 105.77%
40,812 $4.96 Million
Q1 2023

May 09, 2023

SELL
$135.66 - $197.02 $2.79 Million - $4.05 Million
-20,565 Reduced 50.9%
19,834 $3.05 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $615,457 - $1.09 Million
-5,199 Reduced 11.4%
40,399 $7.26 Million
Q3 2022

Nov 10, 2022

BUY
$118.07 - $194.18 $1.02 Million - $1.68 Million
8,651 Added 23.41%
45,598 $5.39 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $2.49 Million - $3.76 Million
-21,294 Reduced 36.56%
36,947 $5.28 Million
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $2.16 Million - $4.02 Million
17,112 Added 41.61%
58,241 $10 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $7.6 Million - $12.4 Million
33,658 Added 450.52%
41,129 $10.4 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $1.19 Million - $2.6 Million
-5,369 Reduced 41.81%
7,471 $2.88 Million
Q3 2020

Nov 16, 2020

BUY
$54.34 - $94.85 $697,725 - $1.22 Million
12,840 New
12,840 $908,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $45.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.